Pounce™ Thrombectomy System Retrospective Registryfor Peripheral Arterial Disease9 locations incl. PeoriaSponsor: SurModics, Inc.Sex: All·Age: 18+Code: NCT05868161·RecruitingApply to this trial
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injuryfor Acute Kidney Injury38 locations incl. BirminghamSponsor: SeaStar MedicalSex: All·Age: 18+Code: NCT05758077·RecruitingApply to this trial
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplantfor Pre-Bronchiolitis Obliterans Syndrome20 locations incl. PhoenixSponsor: Renovion, Inc.Sex: All·Age: 18 - 75Code: NCT05654922·Phase 3·RecruitingApply to this trial
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)for Respiratory Distress Syndrome, Acute11 locations incl. Washington D.C.Sponsor: GEn1E LifesciencesSex: All·Age: 18 - 85Code: NCT05795465·Phase 2·RecruitingApply to this trial
Longitudinal Study for Central Nervous System Vasculitisfor Central Nervous System Vasculitis4 locations incl. RochesterSponsor: University of PennsylvaniaSex: All·Age: 18+Code: NCT05734404·RecruitingApply to this trial
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myelomafor Relapsed/Refractory Multiple Myeloma16 locations incl. BirminghamSponsor: Caribou Biosciences, Inc.Sex: All·Age: 18+Code: NCT05722418·Phase 1·RecruitingApply to this trial
Pilot/Pivotal Study of DBS+Rehab After Strokefor Stroke10 locations incl. PhoenixSponsor: Enspire DBS Therapy, Inc.Sex: All·Age: 21+Code: NCT05701280·RecruitingApply to this trial
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)for Arrhythmogenic Right Ventricular Cardiomyopathy8 locations incl. San FranciscoSponsor: Tenaya TherapeuticsSex: All·Age: 14 - 65Code: NCT06311708·RecruitingApply to this trial
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)for Autosomal Recessive Polycystic Kidney (ARPKD)12 locations incl. Washington D.C.Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.Sex: All·Age: 28 Days - 18Code: NCT04782258·Phase 3·RecruitingApply to this trial
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)for H3 K27M67 locations incl. PhoenixSponsor: Jazz PharmaceuticalsSex: All·Age: All agesCode: NCT05580562·Phase 3·RecruitingApply to this trial
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Agefor Pregnancy Preterm3 locations incl. ClevelandSponsor: University Hospitals Cleveland Medical CenterSex: Female·Age: 18+·Accepts healthy volunteersCode: NCT05345457·Phase 4·RecruitingApply to this trial
Alleviant ALLAY-HF Studyfor Heart Failure53 locations incl. BirminghamSponsor: Alleviant Medical, Inc.Sex: All·Age: 40+Code: NCT05685303·Enrolling By Invitation
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosisfor Venous Thromboembolism48 locations incl. ScottsdaleSponsor: Inari MedicalSex: All·Age: 18+Code: NCT05701917·RecruitingApply to this trial
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstructionfor Patellar Dislocation, Recurrent16 locations incl. Redwood CitySponsor: Hospital for Special Surgery, New YorkSex: All·Age: 10 - 35Code: NCT06883396·RecruitingApply to this trial
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"for Heart Failure1 location in ClevelandSponsor: NHS Greater Glasgow and ClydeSex: All·Age: 40+Code: NCT05919342·RecruitingApply to this trial
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Studyfor Advanced Clear Cell Renal Cell Carcinoma6 locations incl. DuarteSponsor: Vanderbilt-Ingram Cancer CenterSex: All·Age: 18+Code: NCT05361720·Phase 2·RecruitingApply to this trial
Intracardiac Echocardiography Guided Watchman Device Implantfor Atrial Fibrillation1 location in ClevelandSponsor: The Cleveland ClinicSex: All·Age: 18+Code: NCT06007872·RecruitingApply to this trial
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriersfor Amyloidosis, Hereditary3 locations incl. New YorkSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 30 - 80Code: NCT05489549·RecruitingApply to this trial
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissuefor Pediatric Sarcoma, Refractory22 locations incl. South BirminghamSponsor: Nationwide Children's HospitalSex: All·Age: 2 - 40Code: NCT05634369·Phase 1, Phase 2·RecruitingApply to this trial
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancerfor Carcinoma, Non-small-Cell LungDrug: Amivantamab26 locations incl. La JollaSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT05498428·Phase 2·RecruitingApply to this trial
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatmentfor Small Cell Lung Cancer5 locations incl. BirminghamSponsor: Advenchen Pharmaceuticals, LLC.Sex: All·Age: 18+Code: NCT05363280·Phase 2·RecruitingApply to this trial
Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomyfor Mastectomy5 locations incl. Los AngelesSponsor: University of California, San DiegoSex: All·Age: 18+Code: NCT05444361·Enrolling By Invitation
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)for Low Risk Myelodysplastic Syndromes15 locations incl. Los AngelesSponsor: Rigel PharmaceuticalsSex: All·Age: 18+Code: NCT05308264·Phase 1, Phase 2·RecruitingApply to this trial
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Diseasefor Idiopathic Pulmonary Fibrosis86 locations incl. BirminghamSponsor: United TherapeuticsSex: All·Age: 40+Code: NCT04905693·Phase 3·Enrolling By Invitation
TVMR With the INNOVALVE System Trial - Early Feasibility Studyfor Mitral Valve Regurgitation (Degenerative or Functional)20 locations incl. Los AngelesSponsor: Edwards LifesciencesSex: All·Age: 18+Code: NCT04919980·RecruitingApply to this trial
HA35 Moderate Alcoholic Hepatitis (AH) Studyfor Alcoholic Hepatitis1 location in ClevelandSponsor: The Cleveland ClinicSex: All·Age: 21 - 65Code: NCT05018481·EARLY_Phase 1·RecruitingApply to this trial
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)for Platinum-resistant Ovarian CancerDrug: Bevacizumab31 locations incl. MobileSponsor: Genelux CorporationSex: Female·Age: 18+Code: NCT05281471·Phase 3·RecruitingApply to this trial
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancerfor HR+/HER2-negative Breast Cancer10 locations incl. Loma LindaSponsor: SynDevRx, Inc.Sex: All·Age: 18+Code: NCT05455619·Phase 1, Phase 2·RecruitingApply to this trial
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)for Obstructive Hypertrophic CardiomyopathyDrug: Mavacamten62 locations incl. AnchorageSponsor: Bristol-Myers SquibbSex: All·Age: 18+Code: NCT05489705·RecruitingApply to this trial
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathyfor Peripartum Cardiomyopathy, Postpartum64 locations incl. BirminghamSponsor: Dennis M. McNamara, MD, MSSex: Female·Age: 18+Code: NCT05180773·Phase 4·RecruitingApply to this trial
Robotic Versus Open Ventral Hernia Repairfor Ventral Hernia4 locations incl. GainesvilleSponsor: Lucas BeffaSex: All·Age: 18+·Accepts healthy volunteersCode: NCT05472987·RecruitingApply to this trial
Mesh Removal Versus No Mesh Removal for Chronic Groin Pain After Inguinal Hernia Repairfor Chronic Groin Pain1 location in ClevelandSponsor: David KrpataSex: All·Age: 18+·Accepts healthy volunteersCode: NCT05484635·RecruitingApply to this trial
Study of INCB123667 in Subjects With Advanced Solid Tumorsfor Solid TumorsDrug: INCB12366719 locations incl. DuarteSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT05238922·Phase 1·RecruitingApply to this trial
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.for Melanoma31 locations incl. FayettevilleSponsor: PfizerSex: All·Age: 16+Code: NCT05355701·Phase 1·RecruitingApply to this trial
Abatacept in Immune Checkpoint Inhibitor Myocarditisfor Myocarditis Acute29 locations incl. Los AngelesSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05335928·Phase 3·RecruitingApply to this trial
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)for Lumbar Disc Disease19 locations incl. BirminghamSponsor: BioRestorative TherapiesSex: All·Age: 18+Code: NCT04042844·Phase 2·RecruitingApply to this trial
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemiafor Myelofibrosis22 locations incl. DuarteSponsor: Disc Medicine, IncSex: All·Age: 18+Code: NCT05320198·Phase 1, Phase 2·RecruitingApply to this trial
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitisfor Colitis, Ulcerative36 locations incl. PhoenixSponsor: Bristol-Myers SquibbSex: All·Age: 2 - 17Code: NCT05076175·Phase 2, Phase 3·RecruitingApply to this trial
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARBfor FSGS54 locations incl. BirminghamSponsor: Dimerix Bioscience Pty LtdSex: All·Age: 12 - 80Code: NCT05183646·Phase 3·RecruitingApply to this trial
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patientsfor Arrythmia19 locations incl. PhoenixSponsor: University of RochesterSex: All·Age: 18+Code: NCT05034432·Phase 4·RecruitingApply to this trial